J Matthew Singleton
Director at Viking Therapeutics, Inc. (VKTX)
J Matthew Singleton has filed 15 insider reports with the SEC since January 2022, as director at Viking Therapeutics, Inc. (VKTX). J Matthew Singleton made no open-market purchases or sales in the last 12 months. The latest filing, on January 6, 2026, reports grant or award at Viking Therapeutics, Inc. (VKTX).
- Filings
- 15
- Companies
- 1
- Bought on market
- None
- Sold on market
- $4.58M
Companies where J Matthew Singleton is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 12,650 | $4.58M | $24.77 | Jan 6, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jan 2, 2026VKTXDirector Singleton J Matthew was granted 3,150 shares, increasing direct ownership by 33% to 12,650 unitsForm 4Grant or award
- Jan 2, 2025VKTXSEC Form 4 filed by Director Singleton J MatthewForm 4Grant or award
- Oct 25, 2024-$1.27MVKTXDirector Singleton J Matthew exercised 16,000 shares at a strike of $4.48 and sold $1,272,000 worth of shares (16,000 units at $79.50)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Oct 25, 2024~$1.27MVKTXJ Matthew Singleton plans to sell 16,000 shares (~$1.27M)Form 144Planned sale10b5-1 plan
- Sep 20, 2024-$716KVKTXDirector Singleton J Matthew exercised 10,300 shares at a strike of $1.19 and sold $715,850 worth of shares (10,300 units at $69.50)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 20, 2024~$716KVKTXJ Matthew Singleton plans to sell 10,300 shares (~$716K)Form 144Planned sale10b5-1 plan
- Aug 21, 2024-$397KVKTXDirector Singleton J Matthew exercised 5,700 shares at a strike of $1.19 and sold $397,430 worth of shares (5,700 units at $69.72)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 21, 2024~$397KVKTXJ Matthew Singleton plans to sell 5,700 shares (~$397K)Form 144Planned sale10b5-1 plan
- Aug 19, 2024-$995KVKTXDirector Singleton J Matthew exercised 16,000 shares at a strike of $3.33 and sold $995,453 worth of shares (16,000 units at $62.22)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 19, 2024~$995KVKTXJ Matthew Singleton plans to sell 16,000 shares (~$995K)Form 144Planned sale10b5-1 plan
- Aug 14, 2024-$1.2MVKTXDirector Singleton J Matthew exercised 20,786 shares at a strike of $8.00 and sold $1,195,736 worth of shares (20,786 units at $57.53)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 14, 2024~$1.2MVKTXJ Matthew Singleton plans to sell 20,786 shares (~$1.2M)Form 144Planned sale10b5-1 plan
- Jan 2, 2024VKTXSEC Form 4 filed by Singleton J MatthewForm 4Grant or award
- Jan 3, 2023VKTXSEC Form 4 filed by Singleton J MatthewForm 4Grant or award
- Jan 3, 2022VKTXSEC Form 4 filed by Singleton J MatthewForm 4Grant or award
Compare J Matthew Singleton with
- J Matthew Singleton vs Dorothy Elizabeth Kelly-Gemmell1 shared
- J Matthew Singleton vs Brian Lian1 shared
- J Matthew Singleton vs Greg Zante1 shared
- J Matthew Singleton vs Marianna Mancini1 shared
- J Matthew Singleton vs Hubert C Chen1 shared
- J Matthew Singleton vs Neil William Aubuchon1 shared
Other insiders at the same companies
- Dorothy Elizabeth Kelly-GemmellVKTX
- Brian LianVKTX
- Greg ZanteVKTX
- Marianna ManciniVKTX
- Hubert C ChenVKTX
- Neil William AubuchonVKTX
- Lawson MacartneyVKTX
- Charles A Rowland JrVKTX
- Matthew W FoehrVKTX
- Sarah Kathryn RouanVKTX
Questions about J Matthew Singleton
- What is J Matthew Singleton's role at Viking Therapeutics, Inc.?
- J Matthew Singleton reports to the SEC as director at Viking Therapeutics, Inc. (VKTX), according to the latest filing on January 6, 2026.
- How many shares does J Matthew Singleton own?
- After the latest filing that states it, J Matthew Singleton directly owned 12,650 shares of Viking Therapeutics, Inc. (VKTX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has J Matthew Singleton bought or sold stock recently?
- The most recent open-market sale was on October 25, 2024: sold 16,000 shares of Viking Therapeutics, Inc. (VKTX) for $1.27M at an average of $79.50.
- How do I get alerts when J Matthew Singleton files?
- Follow J Matthew Singleton on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by J Matthew Singleton (SEC CIK 0001243514). Totals count each trade once, skipping amendments whose original is on file, from Jan 6, 2022 on. View on SEC EDGAR · Get this as JSON